Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Review

The Role of Wnt Signaling in Physiological and Pathological Angiogenesis

Elisabetta Dejana
Michael Kühl
Download PDF
https://doi.org/10.1161/CIRCRESAHA.110.223750
Circulation Research. 2010;107:943-952
Originally published October 14, 2010
Elisabetta Dejana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Kühl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Abstract
    • Transcriptional Regulation of Endothelial Cell Differentiation
    • Wnt Signaling in Endothelial Cells
    • Noncanonical β-Catenin–Independent Wnt Signaling Pathways in Endothelial Cells
    • Canonical Wnt Signaling in the Embryo Vasculature
    • The Role of Wnt in Eye and Brain Vasculature
    • Wnt Mechanism of Action
    • The Complexity of Canonic Wnt Signaling in Endothelial Cells
    • Wnt and Vascular Pathology
    • Conclusions
    • Sources of Funding
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

Early stages of vascular development include endothelial cell differentiation in a network of arteries, veins, and lymphatics. Subsequently, to respond to the specific needs of the organs, endothelial cells acquire specialized properties such as permeability control, expression of specific transcellular transport systems, membrane adhesive molecules, and others. Endothelial cell differentiation depends on communication between the surrounding tissues, which is mediated by growth and differentiation factors able to activate specific gene expression programs. Recent reports underline the important role of the Wnt system in vascular morphogenesis in the embryo and in organ-specific endothelial differentiation. Wnt signaling regulates fundamental aspects of development, including cell fate specification, proliferation, and survival, and may use different receptors and signaling pathways. Both loss- and gain-of-function experiments of members of the Wnt signaling pathway were found to cause marked alterations of vascular development and endothelial cell specification. Furthermore, altered Wnt signaling in the endothelium may contribute to pathological conditions such as retinopathies, pulmonary arterial hypertension, stroke, and others. Continued progress in this field holds the potential to identify novel therapeutics for the treatment of these diseases.

  • Wnt
  • β-catenin
  • angiogenesis
  • endothelial cells
  • transcription factors

Blood vessels form a large network of arteries, capillaries, and veins, which provide transport of fluids, gases, macromolecules, and cells within the body.1,–,5 During vertebrate development, blood vessels arise through differentiation of mesodermal progenitor cells called angioblasts into endothelial cells. Endothelial progenitors first assemble into a primitive vascular plexus of the extra embryonic yolk sac and into the aortic primordial of the embryo proper. This process, which includes endothelial cell differentiation, proliferation, and migration has been defined vasculogenesis.1 At subsequent steps of development, the vascular plexus is remodeled into a complex system that includes arteries, veins, capillaries, and, to a later stage, lymphatics. The process includes sprouting and expansion of the preexisting vasculature, endothelial cell expression of vascular and organ-specific characteristics, and recruitment of mural cells.2,–,6 Vascular remodeling is needed for the development of an efficient system able to sustain shear stress and transport nutrients and oxygen to the different regions of the organism. Subsequently, to respond to the specific needs of the organs, endothelial cells acquire specialized properties, such as permeability control, expression of specific transcellular transport systems, expression of membrane adhesive molecules, production and binding of chemokines, control of leukocyte traffic, regulation of blood flow, and others. This further level of endothelial cell specialization is induced by the crosstalk with the cells of the surrounding tissues that produce growth and differentiation factors able to activate specific gene expression programs in endothelial cells (see Figure 1). The failure of an appropriate response of endothelial cells to organ-specific requirements may contribute to the pathogenesis of several diseases.4

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Schematic representation of different stages of vascular development. Endothelial cells differentiate from mesodermal progenitors called angioblasts, acquire specific markers, and form the primitive vascular plexus. The plexus undergo further remodeling in large and small vessels, arteries, veins, and lymphatics. Endothelial cells then acquire organ-specific characteristics that are induced by the crosstalk with cells of the surrounding tissues. All of these steps of endothelial differentiation are regulated by sets of transcription factors, which, in the figure, are listed in boxes corresponding to specific types of vessels.

Transcriptional Regulation of Endothelial Cell Differentiation

All the steps of endothelial cell differentiation are orchestrated by specific transcription factors (Figure 1). Some of the transcriptional mechanisms that determine endothelial identity and then arterial, venous, or lymphatic differentiation have been partially identified (reviewed elsewhere7). However, very little is known about the transcription factors that induce organ-specific differentiation of the endothelium.

During the last decade, several groups dedicated a considerable effort in trying to decode the transcriptional mechanisms directing cells of mesodermal origin toward a specific endothelial identity. In contrast to other tissues, endothelial cell differentiation is mediated by several transcription factors that are not cell-specific but act in concert to modulate expression of vascular markers. Through the analysis of the promoter regions of endothelial-specific genes, different transcription factors have been identified as putative inducers of a “common” endothelial cell identity8: these include members of the Ets family, several homeobox (Hox) transcription factors, and members of Soxs (Sry-related high-mobility group box), in particular, the F subgroup (Sox18, Sox17, and Sox7). However, the identification of the specific transcription factors within each class able to transactivate one or another gene has been only partially accomplished.

After acquisition of “panendothelial” characteristics, endothelial cells undergo further differentiation. It was believed that arterial and venous determination was mostly attributable to endothelial exposure to differing blood flow rates and pressure. However, several studies on different animal models suggest that venous and arterial determination precedes the onset of the circulation (reviewed elsewhere2,3,7,–,9). Notch signaling and activation of downstream transcription factors (Hey1 and Hey2 [Hes-related proteins]) are required to promote arterial differentiation and to suppress venous fate choices.10,11 In contrast, the transcription factor COUP-TFII is required for venous identity. This factor acts by inhibiting Notch signaling and other effectors of arterial specification.12 Lymphatic endothelial cells differentiate from venous endothelium. The transcriptional factor Sox18, in cooperation with COUP-TFII, promotes expression of Prox-1, which plays a crucial role in final lymphatic determination and maintenance.13 Other transcription factors such as FOXC1 and FOXC2 act in lymphatic remodeling and valve formation.5,14,–,16

Wnt Signaling in Endothelial Cells

Recent reports underline the important role of the Wnt system in vascular morphogenesis in the embryo and in organ-specific endothelial cell differentiation.4,17,–,21

Wnt signaling regulates fundamental aspects of development including cell fate specification, proliferation, survival, and overall organogenesis (reviewed elsewhere17,22,–,26). For an updated and comprehensive review of these aspects in the cardiovascular system, see the article by Rao and Kühl27 in this same series of reviews. Wnt factors use different receptors and signaling pathways. The most-studied and best-understood Wnt signaling pathway is mediated by the transcriptional activity of β-catenin (Figure 2). In absence of Wnt, cytoplasmic β-catenin is degraded by the action of a multiprotein complex (reviewed elsewhere22,–,28), and Wnt target genes are repressed. The binding of Wnt to the Frizzled/Lrp (low-density lipoprotein receptor–related protein) receptor complex inhibits β-catenin degradation complex and stabilizes β-catenin in the cytoplasm, promoting its translocation to the nucleus. In the nucleus, β-catenin interacts with T-cell factor (TCF)/Lef transcription factors and activates cell transcription.22,29,–,33

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

β-Catenin–dependent/canonical Wnt signaling in the endothelium. The figure represents 3 contiguous cells. In the presence of Wnt, Frizzled receptors and Lrp5/6 complexes are triggered, and this leads to β-catenin stabilization in the cytoplasm and translocation to the nucleus. In the nucleus, β-catenin binds TCF/Lef transcription factors, inducing Wnt target gene transcription. In the retina vasculature, Frizzled receptors may bind Norrin and are multimerized with the contribution of the tetraspanin protein TSPAN21. R-spondin activates Wnt signaling through LRP binding, whereas DKK and SERPINA3K inhibit the binding of Wnt to these receptor elements. The figure is based on previously published reviews.17,22,–,24,26,28,54 β-Catenin is also linked to cadherins (VE-cadherin in endothelial cells) in confluent cells. When cells are migrating, as in sprouting vessels, or exposed to growth or permeability increasing agents, β-catenin may detach from the membrane and translocate to the nucleus.37,51 This mechanism contributes further to β-catenin transcriptional signaling.

Of note, β-catenin also binds to cadherins (VE- and N-cadherin in endothelial cells) at cell-to-cell adherens junctions and stabilizes their interaction with the cytoskeleton (Figure 2). In this way, β-catenin acts by stabilizing cell-to-cell adhesion and tissue integrity.34,35 However, when cells are migrating or in sparse conditions and junctions are partially dismantled, a pool of β-catenin36,37 dissociates from junctions and translocates to the nucleus. In nonvascular cells, recent evidence suggests that there are 2 pools of β-catenin at the membrane.38 One is linked to the cadherin complex, which is protected from degradation. A second pool of β-catenin associates to a membrane bound phosphodestruction complex formed by adenomatous polyposis coli (APC) and GSK3, which promotes its degradation. Cadherins can promote the binding of β-catenin to the complex and limits in this way Wnt signaling. Thus, Wnt signaling is indirectly modulated by intercellular junctions.

The Wnt factors can signal also through noncanonical β-catenin–independent pathways.24,–,28

The Ca2+ pathway is induced by the binding of some members of the Wnt family to specific Frizzled receptors, which, in turn, activate the phospholipase C and increase intracellular Ca2+.23,24

Another β-catenin–independent Wnt signaling pathway is the planar cell polarity (PCP) pathway, which activates the small GTPases RhoA and Rac and modulates cytoskeletal rearrangements and PCP.23,24,39

Which Wnt ligand binds and activates which Frizzled receptor and whether all Frizzled receptors trigger β-catenin dependent or independent signaling remains an open issue. Different Wnt receptors are responsible for inducing one or another signaling pathway, although some receptors40 may activate both canonical and noncanonical pathways. It is likely that the final response is cell context–dependent, ie, related to the type of receptors expressed and the presence or absence of signaling partners in a given cell type at a given moment.

Noncanonical β-Catenin–Independent Wnt Signaling Pathways in Endothelial Cells

Some recent publications underline the importance of noncanonical Wnt pathways in regulating endothelial cell growth and angiogenesis.20,40,–,44 Wnt activation of the Ca2+ pathway induces cell proliferation and inhibits apoptosis in cultured endothelial cells, suggesting a proangiogenic activity in vivo.41,42 PCP also plays a role in vascular morphology, vessel sprouting, and elongation, suggesting a morphogenetic role for this Wnt signaling pathway in vascular development.44 Recently, a member of a subgroup of formins (DAAM1 [Dishevelled-associated activator of morphogenesis]) was found to act downstream of the Wnt/PCP pathway in inhibiting endothelial cell proliferation and angiogenesis.45 The mechanism of action of DAAM1 is likely to coordinate microtubule assembly and stabilization in the endothelium.

Although the molecular basis of β-catenin–independent signaling pathways is still poorly understood, there is a general consensus that β-catenin–independent signaling antagonizes β-catenin pathway.24 Crosstalk between the different Wnt signaling cascades is possible, and it is also possible that all Frizzled receptors may couple to β-catenin–dependent and –independent pathways. Samarzija et al46 observed that Wnt3a induces proliferation and migration of endothelial cells via canonical and noncanonical Wnt signaling pathways.

Using an embryonic stem cells (ES) differentiation system in vitro, Yamashita et al47 reported that activation of the cells with Wnt3a, which mostly signals through β-catenin, preferentially augments endothelial differentiation while inhibiting cardiomyocyte differentiation. However, Hwang et al,48 using a similar system, found that Wnt5a, which most frequently signals through noncanonical pathways, directs endothelial differentiation. These observations underline the complexity of the system and how cell responses may be determined by the cellular context, number, and types of Wnt receptors which are activated.

Another β-catenin–independent pathway is mediated by phosphorylation of APC (a member of the destruction complex of β-catenin).49 It has been reported that phosphorylated APC localizes at the tips of cellular extension during cell migration and is required for cell migration and cytoskeletal organization.49 These effects are independent of β-catenin transcriptional activity.

Overall, data available on noncanonical Wnt signaling in vascular development are still scarce, and additional investigation is required to define which functions and at which steps of embryo development noncanonical Wnt pathways may act. The following part of the review is mostly focused on β-catenin–dependent signaling on which more data are currently available.

Canonical Wnt Signaling in the Embryo Vasculature

By a systematic RT-PCR analysis, it was found that cultured endothelial cells express quite a large array of Frizzled receptors and Wnt factors, together with Lrp5/6.50 This suggests that endothelial cells may be particularly sensitive to Wnt signaling and possibly undergo autocrine stimulation. However, reporter transgenic mouse lines in which Lac-Z expression is under the control of β-catenin–TCF/Lef complex showed relatively low activation of β-catenin transcriptional signaling in the resting vasculature of adult mice. In contrast, detectable activation of Wnt signaling was observed during embryonic development51 in many types of vessels and in the brain microvasculature (see below). Thus, Wnt signaling is important at early steps of vasculogenesis and angiogenesis but is likely silenced in healthy, resting vasculature.

This possibility is confirmed by gene inactivation experiments of different members of the Wnt signaling pathway (for a comprehensive review of these mouse embryo phenotypes, see Franco et al17). Ablation of Frizzled-552 and Wnt 253 leads to a defective placenta vascularization and, in the case of Frizzled-5, also to defective remodeling of the yolk sac vasculature. Similarly, both loss-of-function and gain-of-function mutations of Frizzled-4 and Lrp5 resulted in early lethality of the mouse embryo resulting from defects of vascular organization, remodeling, and mesenchymal cell coverage.54

Inactivation of R-spondin, a coactivator of Wnt/β-catenin,55 caused defective placentation and vascular patterning. It was suggested that these defects were attributable to lack of correct angiogenesis and altered angioblast and blood cell specification.

Endothelial-specific deletion of β-catenin affects the development of the embryonic vasculature and results in early lethality in utero.56 The embryos present defective vascular remodeling and diffuse hemorrhages. In some regions, such as the intersomitic vessels or umbilical veins and arteries, the vessels show hyperbranching.51,56 These alterations were accompanied by changes in the molecular architecture of endothelial adherens junctions, explaining, in part, the presence of hemorrhages, but defects in the transcriptional activity of β-catenin can also contribute to the development of this pathological phenotype.

Furthermore, loss of β-catenin impairs the development of the endocardial cushion and cardiac valves because of altered endothelial mesenchymal transition.57

An even more dramatic phenotype was observed by inducing endothelial-specific stabilization (gain of function) of β-catenin.51,58 The phenotype was characterized by lack of vascular remodeling, altered elongation of the intersomitic vessels, defects in branching, and loss of venous identity. Consistently, endothelial-specific gain-of-function mutation of Frizzled-4 caused similar alterations in the development and specification of the vasculature.54 Taken together, these data indicate that β-catenin/Wnt signaling must be strictly controlled for harmonic vascular development. Too much or too little signaling may prevent a correct vascular organization and lead to early fetal lethality.

The Role of Wnt in Eye and Brain Vasculature

β-Catenin–dependent Wnt signaling is strongly implicated in the development and differentiation of retina and brain microvasculature. These particular vessels express many common functional and morphological characteristics, such as well-developed tight junctions and a specialized and selective system of membrane transporters.59 This vasculature forms the so-called blood–brain barrier (BBB), which is characterized by a strict control of permeability between blood and the central nervous system. In reporter mice, Wnt signaling was particularly strong during early stages of both retina and brain vascularization.60,–,62

In the retina, different strategies such as null mutations of Frizzled- 4, Lrp5, Lef-1,54,60,63,64 and Norrin54 (see below) were used to abrogate canonical Wnt signaling. All of these conditions induced similar vascular alterations, such as absence of intraretinal capillaries, defects in vascular patterning, arteriovenous anastomosis, and intraocular hemorrhages. Inactivation of the Wnt cofactor Nrarp also caused defects of retina vasculature, with decrease in branching and radial expansion.60

In the embryonic brain, Wnt signaling was quite strong in vessels penetrating into the brain stroma and was still detectable during early postnatal period but declined in the adult.61,65 Wnt signaling followed the same kinetics of brain angiogenesis and BBB development, supporting the idea that Wnts are involved in brain vascularization and induction of BBB properties. Further support of this concept derives from inactivation of Wnt signaling through different strategies, such as ablation of endothelial β-catenin61,62 or of Wnt 7a and -b66 or administration of the soluble inhibitor Frizzled-8 receptor construct.62 Without canonical Wnt signaling, the vessels in the brain parenchyma look enlarged and hemorrhagic. In some regions, endothelial cells grow in multilayers into the vascular lumen, forming multicellular structures.

When β-catenin was ablated postnatally (from postnatal day 1 to 11) vascular morphology was not significantly modified, but vessels presented lack of BBB differentiation and control of permeability.61 These data suggest that β-catenin signaling is important for a correct brain and retina angiogenesis during development and, at later stages, for inducing BBB properties in the brain microvasculature.

Wnt signaling plays opposite effects in the hyaloids vessels. These vessels form a capillary network within the developing eye, which must regress at late stages of development. Regression is mediated by Wnt 7b released by adjacent macrophages.67 Consistently, abrogation of Frizzled-5 also inhibits regression of hyaloid vessels.68

Wnt Mechanism of Action

An important issue is the definition of the mechanism of action of canonical Wnt signaling in modulating vascular morphogenesis. Several downstream cofactors and synergistic pathways have been described in endothelial cells of developing vessels.

Corada et al51 found that during vascular development in the embryo, an endothelial-specific gain-of-function mutation of β-catenin induces activation of the Notch pathway. More specifically, β-catenin increases the transcription of the Notch ligand Delta-like (Dll)4, which, in turn, activates Notch-1 and -4. Overexpression of β-catenin leads to alterations of vascular morphology comparable to those described by overexpression of Dll4,69 which include a strong induction of endothelial cell arterialization and lack of venous specification. These effects of β-catenin were detectable only during embryonic vasculogenesis and angiogenesis but were lost in the adult. It appears, therefore, that Wnt and Notch pathways act synergistically in modulating vascular differentiation (Figure 3). On this line, a recent publication70 showed that, using an embryonic stem cell differentiation system in vitro, endothelial cell expression of arterial markers is induced by the synergistic activity of Notch and β-catenin. β-Catenin forms a transcriptional complex with RBP-J transcription factor and the intracellular domain of Notch (NICD), which modulates the transcriptional upregulation of arterial genes. Furthermore, it was found60 that in the retina vasculature, Notch increases the expression of Nrarp, a transcription factor that, from one side, inhibits Notch activation and, on the other, increases β-catenin signaling by activating Lef-1.60 Overall, these data determine a sequential and direct link between β-catenin and Notch signaling systems to tune endothelial cell differentiation and vascular morphogenesis (Figure 3).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Crosstalk between Wnt and Notch signaling pathways in the endothelium. Notch signaling is mediated by binding of Notch receptors to ligands such as Jagged and Dll4. This induces cleavage of the Notch intracellular peptide NICD, which translocates to the nucleus and mediates cell transcription. Notch increases Nrarp expression; Nrarp, in turn, acts as a negative-feedback mechanism, inactivating Notch signaling while activating β-catenin signaling through interaction with Lef-1. Wnt signaling also synergizes with Notch by upregulating Dll4 and by β-catenin binding to NICD–RBP-J complex.6,70

Ye et al54 found that, in endothelial cells, a gain-of-function mutation of Frizzled-4, increases the level of the transcription factor Sox 17. Through in vitro assays, these authors observed that Sox 17 is required for Norrin/Frizzled-4/Lrp–mediated angiogenesis in a 3D matrix gel. Sox17 may bind β-catenin and influence its transcriptional activity,71,72 but how and at which level these 2 transcription factors act on angiogenesis in vivo is still unknown.

TCF4/β-catenin complex increases von Hippel–Lindau tumor suppressor,73 which is required for inactivation of the transcription factor hypoxia-inducible factor (HIF)1α, which, in turn, is a potent inducer of vascular endothelial growth factor (VEGF). In addition, HIF1 α competes with TCF4 for direct binding to β-catenin.74 β-Catenin/HIF1α interaction occurs at the promoter regions of HIF1α target genes and increases their expression. Taken together, these data suggest that at low levels of oxygen, the interaction of β-catenin with HIF1-α may prevail and sustain the response of this transcriptional factor. When normoxia is restored, HIF1α is decreased and TCF4 effectively competes for binding to β-catenin, increases von Hippel–Lindau tumor suppressor, and further promotes HIF1α degradation.

Other partners of canonic Wnt signaling are the members of the FOXO (FOXO1, -2, and -3) subfamily of transcription factors.75 These factors are critically involved in the regulation of apoptosis, proliferation, and oxidative stress.76 Under oxidative stress, FOXOs are increased, and β-catenin binding to them enhances their transcriptional activity. In nonendothelial cells, FOXO competes with TCF4 for interaction with β-catenin, thereby inhibiting TCF 4 transcriptional activity.75

In endothelial cells, Taddei et al37 found that FOXO1 and β-catenin complex binds to claudin 5 promoter and reduces its synthesis. Claudin 5 is an endothelial cell–specific member of the claudin family, which is indispensable for a correct organization of tight junctions. This inhibitory activity of the complex can be released by VE-cadherin expression and clustering at adherens junctions. VE-cadherin can activate phosphoinositide 3-kinase and, in this way, inhibit FOXO1. In addition, VE-cadherin can bind β-catenin and, in confluent cells, recruit this protein at the membrane and limits its nuclear translocation. All of this leads to VE-cadherin–mediated increase in claudin 5, which, in turn, promotes tight junction organization and permeability control.

Another important β-catenin interactor is Smad 2. This transcription factor is associated with transforming growth factor (TGF)β receptor and, on receptor activation, is phosphorylated and translocates to the nucleus.77,78 Smad 2–induced transcription is further dependent on coactivators that stabilize its association to DNA. TGFβ receptors can associate with α3β1 integrin and cadherins (VE-cadherin in endothelial cells79,80 and E-cadherin in the epithelium79. This association generates β-catenin and Smad2 complex, which triggers expression of genes involved in cell motility and epithelial–mesenchymal transition.

Prox1, a key transcription factor in lymphatic differentiation (see above), is also a target of β-catenin/TCF81 in colon cancer.

Taken together, these observations indicate that cell responses to canonic Wnt signaling is strongly influenced by the cell context. β-Catenin may interact with different transcription factors depending on the functional condition of the cells (such as hypoxia, TGFβ signaling, etc). The type of transcription complex formed dictates the downstream cellular responses.

The Complexity of Canonic Wnt Signaling in Endothelial Cells

As a further level of complexity, endothelial cells not only express different Frizzled receptors and Wnt ligands, but they also respond to non-Wnt types of ligands. The best studied to date is Norrin.64

This cysteine knot protein, although structurally unrelated to Wnt factors, is able to bind Frizzled-4 and LRP5/6 complex and potently induce canonical signal (Figure 2). Partial or complete loss-of-function mutations of genes coding for Norrin, Frizzled-4, or Lrp5 induce retina hypovascularization.54 Importantly, these mutations are responsible for the so-called Norrie disease, familial exudative vitreoretinopathy and osteoporosis-pseudoglioma that in human beings causes important defects in retina vascularization.82,83

The mechanism of action of Norrin has been partially disclosed by the discovery of TSPAN12, a member of the tetraspanin protein family.84 The members of this family generate specialized tetraspanin-rich microdomains that function as signaling platforms at the cell membrane.85 It was found that Norrin multimers act together with TSPAN12 to promote Frizzled-4 multimerization and downstream signaling (Figure 2). These data are of particular interest because TSPAN12 is specifically enriched in endothelial cells in the retina but not in other type of vessels or cells. Furthermore, TSPAN12 does not influence Wnt signaling in general but only when is triggered by Norrin. This pathway, therefore, is an example of how β-catenin–dependent signaling may be regulated in a cell- and organ-specific manner.

Another example of a pathway that modulates Wnt signaling in the endothelium is histone deacetylase (HDAC)7.86 It was recently reported that HDAC7 binds and prevents β-catenin nuclear translocation and signaling. VEGF treatment induces HDAC7 degradation and rescues β-catenin nuclear translocation and signaling. Thus, posttranslational modification of β-catenin, such as phosphorylation or acetylation, may strongly influence its signaling.

Other agents known to strongly increase vascular permeability, such as thrombin, were found to induce β-catenin redistribution from cadherins to cytoplasm and nucleus.87,88 Lipid phosphate phosphatase 3 increases β-catenin signaling, which, in turn, induces fibronectin synthesis, endothelial cell migration, and vascular branching.89 These observations support the concept that stimuli that do not belong to the Wnt family may also act through β-catenin signaling, modulating its nuclear availability.

Finally, Wnt signaling may influence endothelial cell responses indirectly. A typical example is given by Aicher et al.90 These authors found that vasculogenic progenitor cell mobilization from the bone marrow is strongly increased by administration of Dkk1, which is an inhibitor of Lrp5/6 (Figure 2). This effect is mediated by osteoclasts, which are induced by Dkk1 to produce cathepsin K, which, in turn, cleaves the adhesive bonds between stem cells and stromal cells in the bone marrow and promotes vasculogenic progenitor mobilization. In this case, therefore, the effect of Wnt inhibition is indirect, involving other cell targets that induce endothelial progenitor mobilization and angiogenic activity.

Wnt and Vascular Pathology

Taking into consideration the different pathways and conditions that may influence or be influenced by Wnt, an important question is whether vascular pathologies may derive from altered Wnt signaling. Given the many circumstances in which Wnt signaling plays a critical function, it is conceivable that this occurs, and few examples have been reported in the literature.

Canonical Wnt signaling can promote retina vascularization. This effect is particularly important in diabetic retinopathy, where neovascularization is accompanied by increased β-catenin nuclear signaling. Interestingly, SERPINA3K, a serine proteinase inhibitor, was found to inhibit Wnt signaling by binding to Lrp6, thus inhibiting its dimerization with Frizzled receptors (Figure 2).91 SERPINA3K was also able to reduce diabetic retinopathy.91

Norrie disease indicates how abrogation of β-catenin signaling may cause profound effects in retinal vascular development (see above). It is tempting to assume that alteration of the Frizzled-4/Norrin system may also play a role in diabetic retinopathy or retinopathy of prematurity92 because it was shown in preclinical models.93 Furthermore, Frizzled-4 expression is quite ubiquitous in endothelial cells of different types of vessels.54 Venous insufficiency94,95 or female infertility related to vascular problems96,97 have been described in Norrie disease, suggesting a more general role of altered β-catenin signaling also in vascular regions outside brain or retina.

Secreted Frizzled-related protein is an inhibitor of Wnt signaling that acts by binding Wnt and antagonizes both canonical and noncanonical Wnt signaling. This protein inhibits angiogenesis in different settings including tumors, suggesting that Wnt may be implicated in proliferative diseases by inducing vascular proliferation.98 Consistently, nuclear localization of β-catenin was observed in coronary endothelial cells in the ischemic heart.99 In these conditions, β-catenin may constitute a defense mechanism to promote angiogenesis in case of hypoxia. Wnt4, produced by mesenchymal stem cells,100 promotes vascular proliferation in ischemia.

Healing of diabetic ulcers appears to be improved by localization of vasculogenic progenitors able to release Wnt factors and activate endothelial cells.101 Canonical Wnt signaling can induce VEGF synthesis in colonic neoplasia, which, in turn, would increase angiogenesis.102 In other conditions, however, the Wnt inhibitor Dkk3 promotes angiogenesis in tumors,103 underlying the difficulties in defining a unique pattern of responses in the different experimental conditions.

Idiopathic pulmonary arterial hypertension is a rare disease linked to mutated bone morphogenetic protein (BMP) receptor II, which causes pulmonary artery endothelial cell apoptosis and loss of small vessels. It was found that binding of BMP to this receptor activates canonical and noncanonical Wnt pathways, which, in turn, promote angiogenesis and inhibit vascular regression.104

Several reports indicate that Wnt signaling plays a crucial role in brain vascularization and BBB differentiation.17,61,62,65,66 Astrocytes produce Wnt, and this factor regulates the architecture and function of the so-called neurovascular unit (see above). It is, therefore, conceivable that any condition that inhibits Wnt signaling during development or after birth may strongly affect brain perfusion and BBB differentiation.105 Vice versa, gain-of-function mutation of Wnt may accelerate establishment of BBB and possibly alter permeability properties in the brain and in other vascular regions.61,62,65,66,105

Conclusions

The study of the role of the Wnt system in vascular development and angiogenesis had a particular upsurge in the most recent years. However, we have only a partial knowledge of how the system works in vascular cells and how can be affected in pathological conditions. It is conceivable that endothelial cells derived from different types of vessels express distinct types of receptors and respond differently to Wnts. Furthermore, Wnt may act in concert with other signaling pathways such as Notch or TGFβ in modulating vascular development and endothelial specification. The same Wnt factor or receptor may induce distinct and sometimes opposite responses in endothelial cells depending on the context, such as, for instance, activation by growth factors, oxygen levels, induction of permeability, expression of transcription factors, etc. Furthermore, endothelial cells may produce not only Wnt ligands106 but also receptor inhibitors such as soluble Frizzled or Dkks,50,106 which may further control and balance Wnt signaling.

Taking all of this into account, it is crucial for future studies to define the specific conditions used, define the cell and vessel type, and combine in vitro with in vivo systems to be able to decipher the complexity of the Wnt pathway. These studies also force us to take into account that endothelial cells are not alike but form a very heterogeneous population that reacts differently to physiological and pathological stimuli.

Sources of Funding

This work was supported by the Fondation Leducq Transatlantic Network of Excellence, Associazione Italiana per la Ricerca sul Cancro, Association for International Cancer Research UK, the European Community (Project Contracts: JUSTBRAIN; EUSTROKE contract 202213, OPTISTEM contract 223098, ANGIOSCAFF NMP3-LA-2008-214402 and ENDOSTEMCELLS Networks), Istituto Superiore di Sanita,' Italian Ministry of Health, and CARIPLO Foundation contract 2008.2463.

Disclosures

None.

Acknowledgments

I thank Fabrizio Orsenigo for valuable help in preparing the figures for this article.

Footnotes

  • In July 2010, the average time from submission to first decision for all original research papers submitted to Circulation Research was 12.9 days.

  • This article is the introduction of a new thematic series on Wnts in Cardiovascular Development and Disease, which includes the following articles:

    An Updated Overview on Wnt Signaling Pathways: A Prelude for More [Circ Res. 2010;106:1798–1806]

    The Multiple Phases and Faces of Wnt Signaling During Cardiac Differentiation and Development [Circ Res. 2010;107:186–199]

    The Role of Wnt Signaling in Physiological and Pathological Angiogenesis

    Wnt Signaling in Cardiac Hypertrophy and Remodeling

    Wnt Signaling and Aging-Related Heart Disorders

    Wnt Signaling and Stem Cells

  • Non-standard Abbreviations and Acronyms

    APC
    adenomatous polyposis coli
    BBB
    blood–brain barrier
    Dll4
    Delta-like 4
    HDAC
    histone deacetylase
    HIF
    hypoxia-inducible factor
    Lrp
    low-density lipoprotein receptor–related protein
    PCP
    planar cell polarity
    Sox
    Sry-related high mobility group box
    TCF
    T-cell factor
    TGF
    transforming growth factor
    VEGF
    vascular endothelial growth factor

  • Received June 30, 2010.
  • Revision received August 16, 2010.
  • Accepted August 18, 2010.
  • © 2010 American Heart Association, Inc.

References

  1. 1.↵
    1. Risau W
    . Mechanisms of angiogenesis. Nature. 1997;386:671–674.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Adams RH,
    2. Alitalo K
    . Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8:464–478.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Carmeliet P,
    2. De Smet F,
    3. Loges S,
    4. Mazzone M
    . Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat Rev Clin Oncol. 2009;6:315–326.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Dejana E,
    2. Tournier-Lasserve E,
    3. Weinstein BM
    . The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell. 2009;16:209–221.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Oliver G,
    2. Srinivasan RS
    . Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell. Development. 2010;137:363–372.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Phng LK,
    2. Gerhardt H
    . Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009;16:196–208.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Dejana E,
    2. Taddei A,
    3. Randi AM
    . Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta. 2007;1775:298–312.
    OpenUrlPubMed
  8. 8.↵
    1. De Val S,
    2. Black BL
    . Transcriptional control of endothelial cell development. Dev Cell. 2009;16:180–195.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Roca C,
    2. Adams RH
    . Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 2007;21:2511–2524.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Lawson ND,
    2. Scheer N,
    3. Pham VN,
    4. Kim CH,
    5. Chitnis AB,
    6. Campos-Ortega JA,
    7. Weinstein BM
    . Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development. 2001;128:3675–3683.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Kim YH,
    2. Hu H,
    3. Guevara-Gallardo S,
    4. Lam MT,
    5. Fong SY,
    6. Wang RA
    . Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. Development. 2008;135:3755–3764.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. You LR,
    2. Lin FJ,
    3. Lee CT,
    4. DeMayo FJ,
    5. Tsai MJ,
    6. Tsai SY
    . Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature. 2005;435:98–104.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Francois M,
    2. Caprini A,
    3. Hosking B,
    4. Orsenigo F,
    5. Wilhelm D,
    6. Browne C,
    7. Paavonen K,
    8. Karnezis T,
    9. Shayan R,
    10. Downes M,
    11. Davidson T,
    12. Tutt D,
    13. Cheah KS,
    14. Stacker SA,
    15. Muscat GE,
    16. Achen MG,
    17. Dejana E,
    18. Koopman P
    . Sox18 induces development of the lymphatic vasculature in mice. Nature. 2008;456:643–647.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Norrmen C,
    2. Ivanov KI,
    3. Cheng J,
    4. Zangger N,
    5. Delorenzi M,
    6. Jaquet M,
    7. Miura N,
    8. Puolakkainen P,
    9. Horsley V,
    10. Hu J,
    11. Augustin HG,
    12. Yla-Herttuala S,
    13. Alitalo K,
    14. Petrova TV
    . FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol. 2009;185:439–457.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Augustin HG,
    2. Koh GY,
    3. Thurston G,
    4. Alitalo K
    . Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009;10:165–177.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Tammela T,
    2. Alitalo K
    . Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010;140:460–476.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Franco CA,
    2. Liebner S,
    3. Gerhardt H
    . Vascular morphogenesis: a Wnt for every vessel? Curr Opin Genet Dev. 2009;19:476–483.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. van de Schans VA,
    2. Smits JF,
    3. Blankesteijn WM
    . The Wnt/frizzled pathway in cardiovascular develpment and disease: Friend or foe? Eur J Pharmacol. 2008;585:338–345.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Cohen ED,
    2. Tian Y,
    3. Morrisey EE
    . Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development. 2008;135:789–798.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Zerlin M,
    2. Julius MA,
    3. Kitajewski J
    . Wnt/Frizzled signaling in angiogenesis. Angiogenesis. 2008;11:63–69.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. van Gijn ME,
    2. Daemen MJ,
    3. Smits JF,
    4. Blankesteijn WM
    . The wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res. 2002;55:16–24.
    OpenUrlFREE Full Text
  22. 22.↵
    1. Clevers H
    . Wnt/beta-catenin signaling in development and disease. Cell. 2006;127:469–480.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. van Amerongen R,
    2. Mikels A,
    3. Nusse R
    . Alternative wnt signaling is initiated by distinct receptors. Sci Signal. 2008;1:re9.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Angers S,
    2. Moon RT
    . Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009;10:468–477.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. MacDonald BT,
    2. Tamai K,
    3. He X
    . Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9–26.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Kikuchi A,
    2. Yamamoto H,
    3. Sato A
    . Selective activation mechanisms of Wnt signaling pathways. Trends Cell Biol. 2009;19:119–129.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Rao TP,
    2. Kühl M
    . An updated overview on Wnt signaling pathways: a prelude for more. Circ Res. 106:1798–1806.
  28. 28.↵
    1. van Amerongen R,
    2. Nusse R
    . Towards an integrated view of Wnt signaling in development. Development. 2009;136:3205–3214.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Wallingford JB,
    2. Habas R
    . The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development. 2005;132:4421–4436.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Cavallo RA,
    2. Cox RT,
    3. Moline MM,
    4. Roose J,
    5. Polevoy GA,
    6. Clevers H,
    7. Peifer M,
    8. Bejsovec A
    . Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature. 1998;395:604–608.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Roose J,
    2. Molenaar M,
    3. Peterson J,
    4. Hurenkamp J,
    5. Brantjes H,
    6. Moerer P,
    7. van de Wetering M,
    8. Destree O,
    9. Clevers H
    . The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature. 1998;395:608–612.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Stadeli R,
    2. Hoffmans R,
    3. Basler K
    . Transcription under the control of nuclear Arm/beta-catenin. Curr Biol. 2006;16:R378–R385.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Mosimann C,
    2. Hausmann G,
    3. Basler K
    . Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell. 2006;125:327–341.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Meng W,
    2. Takeichi M
    . Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol. 2009;1:a002899.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Stepniak E,
    2. Radice GL,
    3. Vasioukhin V
    . Adhesive and signaling functions of cadherins and catenins in vertebrate development. Cold Spring Harb Perspect Biol. 2009;1:a002949.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Heuberger J,
    2. Birchmeier W
    . Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2010;2:a002915.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Taddei A,
    2. Giampietro C,
    3. Conti A,
    4. Orsenigo F,
    5. Breviario F,
    6. Pirazzoli V,
    7. Potente M,
    8. Daly C,
    9. Dimmeler S,
    10. Dejana E
    . Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol. 2008;10:923–934.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Maher MT,
    2. Flozak AS,
    3. Stocker AM,
    4. Chenn A,
    5. Gottardi CJ
    . Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol. 2009;186:219–228.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Seifert JR,
    2. Mlodzik M
    . Frizzled/PCP signalling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet. 2007;8:126–138.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Yang DH,
    2. Yoon JY,
    3. Lee SH,
    4. Bryja V,
    5. Andersson ER,
    6. Arenas E,
    7. Kwon YG,
    8. Choi KY
    . Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha. Circ Res. 2009;104:372–379.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Goodwin AM,
    2. Kitajewski J,
    3. D'Amore PA
    . Wnt1 and Wnt5a affect endothelial proliferation and capillary length; Wnt2 does not. Growth Factors. 2007;25:25–32.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Masckauchan TN,
    2. Agalliu D,
    3. Vorontchikhina M,
    4. Ahn A,
    5. Parmalee NL,
    6. Li CM,
    7. Khoo A,
    8. Tycko B,
    9. Brown AM,
    10. Kitajewski J
    . Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell. 2006;17:5163–5172.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Cheng CW,
    2. Yeh JC,
    3. Fan TP,
    4. Smith SK,
    5. Charnock-Jones DS
    . Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration. Biochem Biophys Res Commun. 2008;365:285–290.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Cirone P,
    2. Lin S,
    3. Griesbach HL,
    4. Zhang Y,
    5. Slusarski DC,
    6. Crews CM
    . A role for planar cell polarity signaling in angiogenesis. Angiogenesis. 2008;11:347–360.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Ju R,
    2. Cirone P,
    3. Lin S,
    4. Griesbach H,
    5. Slusarski DC,
    6. Crews CM
    . Activation of the planar cell polarity formin DAAM1 leads to inhibition of endothelial cell proliferation, migration, and angiogenesis. Proc Natl Acad Sci U S A. 107:6906–6911.
  46. 46.↵
    1. Samarzija I,
    2. Sini P,
    3. Schlange T,
    4. Macdonald G,
    5. Hynes NE
    . Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochem Biophys Res Commun. 2009;386:449–454.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Yamashita JK,
    2. Takano M,
    3. Hiraoka-Kanie M,
    4. Shimazu C,
    5. Peishi Y,
    6. Yanagi K,
    7. Nakano A,
    8. Inoue E,
    9. Kita F,
    10. Nishikawa S
    . Prospective identification of cardiac progenitors by a novel single cell-based cardiomyocyte induction. FASEB J. 2005;19:1534–1536.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Hwang YS,
    2. Chung BG,
    3. Ortmann D,
    4. Hattori N,
    5. Moeller HC,
    6. Khademhosseini A
    . Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A. 2009;106:16978–16983.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    1. Harris ES,
    2. Nelson WJ
    . APC regulates endothelial cell migration independent of roles in {beta}-catenin signaling and cell-cell adhesion. Mol Biol Cell. 2010;21:2611–2623.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Goodwin AM,
    2. Sullivan KM,
    3. D'Amore PA
    . Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling. Dev Dyn. 2006;235:3110–3120.
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. Corada MND,
    2. Orsenigo F,
    3. Caprini A,
    4. Giampietro C,
    5. Taketo MM,
    6. Iruela-Arispe ML,
    7. Adams RH,
    8. Dejana E
    . The Wnt/b-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell. 2010;18:938–949.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Ishikawa T,
    2. Tamai Y,
    3. Zorn AM,
    4. Yoshida H,
    5. Seldin MF,
    6. Nishikawa S,
    7. Taketo MM
    . Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development. 2001;128:25–33.
    OpenUrlAbstract
  53. 53.↵
    1. Monkley SJ,
    2. Delaney SJ,
    3. Pennisi DJ,
    4. Christiansen JH,
    5. Wainwright BJ
    . Targeted disruption of the Wnt2 gene results in placentation defects. Development. 1996;122:3343–3353.
    OpenUrlAbstract
  54. 54.↵
    1. Ye X,
    2. Wang Y,
    3. Cahill H,
    4. Yu M,
    5. Badea TC,
    6. Smallwood PM,
    7. Peachey NS,
    8. Nathans J
    . Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell. 2009;139:285–298.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Kazanskaya O,
    2. Ohkawara B,
    3. Heroult M,
    4. Wu W,
    5. Maltry N,
    6. Augustin HG,
    7. Niehrs C
    . The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development. Development. 2008;135:3655–3664.
    OpenUrlAbstract/FREE Full Text
  56. 56.↵
    1. Cattelino A,
    2. Liebner S,
    3. Gallini R,
    4. Zanetti A,
    5. Balconi G,
    6. Corsi A,
    7. Bianco P,
    8. Wolburg H,
    9. Moore R,
    10. Oreda B,
    11. Kemler R,
    12. Dejana E
    . The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol. 2003;162:1111–1122.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Liebner S,
    2. Cattelino A,
    3. Gallini R,
    4. Rudini N,
    5. Iurlaro M,
    6. Piccolo S,
    7. Dejana E
    . Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol. 2004;166:359–367.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    1. Grigoryan T,
    2. Wend P,
    3. Klaus A,
    4. Birchmeier W
    . Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev. 2008;22:2308–2341.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    1. Engelhardt B
    . Development of the blood-brain barrier. Cell Tissue Res. 2003;314:119–129.
    OpenUrlCrossRefPubMed
  60. 60.↵
    1. Phng LK,
    2. Potente M,
    3. Leslie JD,
    4. Babbage J,
    5. Nyqvist D,
    6. Lobov I,
    7. Ondr JK,
    8. Rao S,
    9. Lang RA,
    10. Thurston G,
    11. Gerhardt H
    . Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev Cell. 2009;16:70–82.
    OpenUrlCrossRefPubMed
  61. 61.↵
    1. Liebner S,
    2. Corada M,
    3. Bangsow T,
    4. Babbage J,
    5. Taddei A,
    6. Czupalla CJ,
    7. Reis M,
    8. Felici A,
    9. Wolburg H,
    10. Fruttiger M,
    11. Taketo MM,
    12. von Melchner H,
    13. Plate KH,
    14. Gerhardt H,
    15. Dejana E
    . Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol. 2008;183:409–417.
    OpenUrlAbstract/FREE Full Text
  62. 62.↵
    1. Daneman R,
    2. Agalliu D,
    3. Zhou L,
    4. Kuhnert F,
    5. Kuo CJ,
    6. Barres BA
    . Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci U S A. 2009;106:641–646.
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    1. Xia CH,
    2. Liu H,
    3. Cheung D,
    4. Wang M,
    5. Cheng C,
    6. Du X,
    7. Chang B,
    8. Beutler B,
    9. Gong X
    . A model for familial exudative vitreoretinopathy caused by LPR5 mutations. Hum Mol Genet. 2008;17:1605–1612.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    1. Xu Q,
    2. Wang Y,
    3. Dabdoub A,
    4. Smallwood PM,
    5. Williams J,
    6. Woods C,
    7. Kelley MW,
    8. Jiang L,
    9. Tasman W,
    10. Zhang K,
    11. Nathans J
    . Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116:883–895.
    OpenUrlCrossRefPubMed
  65. 65.↵
    1. Liebner S,
    2. Plate KH
    . Differentiation of the brain vasculature: the answer came blowing by the Wnt. J Angiogenes Res. 2010;2:1–10.
    OpenUrlCrossRefPubMed
  66. 66.↵
    1. Stenman JM,
    2. Rajagopal J,
    3. Carroll TJ,
    4. Ishibashi M,
    5. McMahon J,
    6. McMahon AP
    . Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science. 2008;322:1247–1250.
    OpenUrlAbstract/FREE Full Text
  67. 67.↵
    1. Lobov IB,
    2. Rao S,
    3. Carroll TJ,
    4. Vallance JE,
    5. Ito M,
    6. Ondr JK,
    7. Kurup S,
    8. Glass DA,
    9. Patel MS,
    10. Shu W,
    11. Morrisey EE,
    12. McMahon AP,
    13. Karsenty G,
    14. Lang RA
    . WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature. 2005;437:417–421.
    OpenUrlCrossRefPubMed
  68. 68.↵
    1. Liu C,
    2. Nathans J
    . An essential role for frizzled 5 in mammalian ocular development. Development. 2008;135:3567–3576.
    OpenUrlAbstract/FREE Full Text
  69. 69.↵
    1. Duarte A,
    2. Hirashima M,
    3. Benedito R,
    4. Trindade A,
    5. Diniz P,
    6. Bekman E,
    7. Costa L,
    8. Henrique D,
    9. Rossant J
    . Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004;18:2474–2478.
    OpenUrlAbstract/FREE Full Text
  70. 70.↵
    1. Kohei Yamamizu TM,
    2. Hideki Uosaki,
    3. Hiroyuki Fukushima,
    4. Shiori Katayama,
    5. Mina Hiraoka-Kanie,
    6. Kohnosuke Mitani,
    7. Jun K
    . Yamashita. Convergence of Notch and β-catenin signaling induces arterial fate in vascular progenitors. J Cell Biol. 2010;189:325–338.
    OpenUrlAbstract/FREE Full Text
  71. 71.↵
    1. Zorn AM,
    2. Barish GD,
    3. Williams BO,
    4. Lavender P,
    5. Klymkowsky MW,
    6. Varmus HE
    . Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell. 1999;4:487–498.
    OpenUrlCrossRefPubMed
  72. 72.↵
    1. Sinner D,
    2. Rankin S,
    3. Lee M,
    4. Zorn AM
    . Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development. 2004;131:3069–3080.
    OpenUrlAbstract/FREE Full Text
  73. 73.↵
    1. Giles RH,
    2. Lolkema MP,
    3. Snijckers CM,
    4. Belderbos M,
    5. van der Groep P,
    6. Mans DA,
    7. van Beest M,
    8. van Noort M,
    9. Goldschmeding R,
    10. van Diest PJ,
    11. Clevers H,
    12. Voest EE
    . Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene. 2006;25:3065–3070.
    OpenUrlCrossRefPubMed
  74. 74.↵
    1. Kaidi A,
    2. Williams AC,
    3. Paraskeva C
    . Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol. 2007;9:210–217.
    OpenUrlCrossRefPubMed
  75. 75.↵
    1. Essers MA,
    2. de Vries-Smits LM,
    3. Barker N,
    4. Polderman PE,
    5. Burgering BM,
    6. Korswagen HC
    . Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science. 2005;308:1181–1184.
    OpenUrlAbstract/FREE Full Text
  76. 76.↵
    1. Burgering BM,
    2. Medema RH
    . Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol. 2003;73:689–701.
    OpenUrlAbstract/FREE Full Text
  77. 77.↵
    1. Derynck R,
    2. Zhang YE
    . Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577–584.
    OpenUrlCrossRefPubMed
  78. 78.↵
    1. Massague J,
    2. Chen YG
    . Controlling TGF-beta signaling. Genes Dev. 2000;14:627–644.
    OpenUrlFREE Full Text
  79. 79.↵
    1. Kim Y,
    2. Kugler MC,
    3. Wei Y,
    4. Kim KK,
    5. Li X,
    6. Brumwell AN,
    7. Chapman HA
    . Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J Cell Biol. 2009;184:309–322.
    OpenUrlAbstract/FREE Full Text
  80. 80.↵
    1. Rudini N,
    2. Felici A,
    3. Giampietro C,
    4. Lampugnani M,
    5. Corada M,
    6. Swirsding K,
    7. Garre M,
    8. Liebner S,
    9. Letarte M,
    10. ten Dijke P,
    11. Dejana E
    . VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J. 2008;27:993–1004.
    OpenUrlCrossRefPubMed
  81. 81.↵
    1. Petrova TV,
    2. Nykanen A,
    3. Norrmen C,
    4. Ivanov KI,
    5. Andersson LC,
    6. Haglund C,
    7. Puolakkainen P,
    8. Wempe F,
    9. von Melchner H,
    10. Gradwohl G,
    11. Vanharanta S,
    12. Aaltonen LA,
    13. Saharinen J,
    14. Gentile M,
    15. Clarke A,
    16. Taipale J,
    17. Oliver G,
    18. Alitalo K
    . Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell. 2008;13:407–419.
    OpenUrlCrossRefPubMed
  82. 82.↵
    1. Ai M,
    2. Heeger S,
    3. Bartels CF,
    4. Schelling DK
    . Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am J Hum Genet. 2005;77:741–753.
    OpenUrlCrossRefPubMed
  83. 83.↵
    1. Toomes C,
    2. Bottomley HM,
    3. Jackson RM,
    4. Towns KV,
    5. Scott S,
    6. Mackey DA,
    7. Craig JE,
    8. Jiang L,
    9. Yang Z,
    10. Trembath R,
    11. Woodruff G,
    12. Gregory-Evans CY,
    13. Gregory-Evans K,
    14. Parker MJ,
    15. Black GC,
    16. Downey LM,
    17. Zhang K,
    18. Inglehearn CF
    . Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet. 2004;74:721–730.
    OpenUrlCrossRefPubMed
  84. 84.↵
    1. Junge HJ,
    2. Yang S,
    3. Burton JB,
    4. Paes K,
    5. Shu X,
    6. French DM,
    7. Costa M,
    8. Rice DS,
    9. Ye W
    . TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling. Cell. 2009;139:299–311.
    OpenUrlCrossRefPubMed
  85. 85.↵
    1. Hemler ME
    . Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005;6:801–811.
    OpenUrlCrossRefPubMed
  86. 86.↵
    1. Margariti A,
    2. Zampetaki A,
    3. Xiao Q,
    4. Zhou B,
    5. Karamariti E,
    6. Martin D,
    7. Yin X,
    8. Mayr M,
    9. Li H,
    10. Zhang Z,
    11. De Falco E,
    12. Hu Y,
    13. Cockerill G,
    14. Xu Q,
    15. Zeng L
    . Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. Circ Res. 106:1202–1211.
  87. 87.↵
    1. Beckers CM,
    2. Garcia-Vallejo JJ,
    3. van Hinsbergh VW,
    4. van Nieuw Amerongen GP
    . Nuclear targeting of beta-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction. Cardiovasc Res. 2008;79:679–688.
    OpenUrlAbstract/FREE Full Text
  88. 88.↵
    1. Ilan N,
    2. Tucker A,
    3. Madri JA
    . Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation? Lab Invest. 2003;83:1105–1115.
    OpenUrlCrossRefPubMed
  89. 89.↵
    1. Humtsoe JO,
    2. Liu M,
    3. Malik AB,
    4. Wary KK
    . Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures. Mol Cell Biol. 2010;30:1593–1606.
    OpenUrlAbstract/FREE Full Text
  90. 90.↵
    1. Aicher AKO,
    2. Heeschen C,
    3. Liebner S,
    4. Urbich C,
    5. Ihling C,
    6. Orlandi A,
    7. Lapidot T,
    8. Zeiher AM,
    9. Dimmeler S
    . The Wnt antagonist Dikkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche. Circ Res. 2010;103:796–803.
    OpenUrl
  91. 91.↵
    1. Zhang B,
    2. Abreu JG,
    3. Zhou K,
    4. Chen Y,
    5. Hu Y,
    6. Zhou T,
    7. He X,
    8. Ma JX
    . Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family. Proc Natl Acad Sci U S A. 2010;107:6900–6905.
    OpenUrlAbstract/FREE Full Text
  92. 92.↵
    1. Shastry BS,
    2. Pendergast SD,
    3. Hartzer MK,
    4. Liu X,
    5. Trese MT
    . Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol. 1997;115:651–655.
    OpenUrlCrossRefPubMed
  93. 93.↵
    1. Chen Y,
    2. Hu Y,
    3. Zhou T,
    4. Zhou KK,
    5. Mott R,
    6. Wu M,
    7. Boulton M,
    8. Lyons TJ,
    9. Gao G,
    10. Ma JX
    . Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol. 2009;175:2676–2685.
    OpenUrlCrossRefPubMed
  94. 94.↵
    1. Rehm HL,
    2. Gutierrez-Espeleta GA,
    3. Garcia R,
    4. Jimenez G,
    5. Khetarpal U,
    6. Priest JM,
    7. Sims KB,
    8. Keats BJ,
    9. Morton CC
    . Norrie disease gene mutation in a large Costa Rican kindred with a novel phenotype including venous insufficiency. Hum Mutat. 1997;9:402–408.
    OpenUrlCrossRefPubMed
  95. 95.↵
    1. Michaelides M,
    2. Luthert PJ,
    3. Cooling R,
    4. Firth H,
    5. Moore AT
    . Norrie disease and peripheral venous insufficiency. Br J Ophthalmol. 2004;88:1475.
    OpenUrlFREE Full Text
  96. 96.↵
    1. Hsieh M,
    2. Boerboom D,
    3. Shimada M,
    4. Lo Y,
    5. Parlow AF,
    6. Luhmann UF,
    7. Berger W,
    8. Richards JS
    . Mice null for Frizzled4 (Fzd4−/−) are infertile and exhibit impaired corpora lutea formation and function. Biol Reprod. 2005;73:1135–1146.
    OpenUrlAbstract/FREE Full Text
  97. 97.↵
    1. Luhmann UF,
    2. Meunier D,
    3. Shi W,
    4. Luttges A,
    5. Pfarrer C,
    6. Fundele R,
    7. Berger W
    . Fetal loss in homozygous mutant Norrie disease mice: a new role of Norrin in reproduction. Genesis. 2005;42:253–262.
    OpenUrlCrossRefPubMed
  98. 98.↵
    1. Muley A,
    2. Majumder S,
    3. Kolluru GK,
    4. Parkinson S,
    5. Viola H,
    6. Hool L,
    7. Arfuso F,
    8. Ganss R,
    9. Dharmarajan A,
    10. Chatterjee S
    . Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol. 2010;176:1505–1516.
    OpenUrlCrossRefPubMed
  99. 99.↵
    1. Blankesteijn WM,
    2. van Gijn ME,
    3. Essers-Janssen YP,
    4. Daemen MJ,
    5. Smits JF
    . Beta-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction. Am J Pathol. 2000;157:877–883.
    OpenUrlCrossRefPubMed
  100. 100.↵
    1. Leroux L,
    2. Descamps B,
    3. Tojais NF,
    4. Seguy B,
    5. Oses P,
    6. Moreau C,
    7. Daret D,
    8. Ivanovic Z,
    9. Boiron JM,
    10. Lamaziere JM,
    11. Dufourcq P,
    12. Couffinhal T,
    13. Duplaa C
    . Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther. 2010;18:1545–1552.
    OpenUrlCrossRefPubMed
  101. 101.↵
    1. Barcelos LS,
    2. Duplaa C,
    3. Krankel N,
    4. Graiani G,
    5. Invernici G,
    6. Katare R,
    7. Siragusa M,
    8. Meloni M,
    9. Campesi I,
    10. Monica M,
    11. Simm A,
    12. Campagnolo P,
    13. Mangialardi G,
    14. Stevanato L,
    15. Alessandri G,
    16. Emanueli C,
    17. Madeddu P
    . Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res. 2009;104:1095–1102.
    OpenUrlAbstract/FREE Full Text
  102. 102.↵
    1. Zhang X,
    2. Gaspard JP,
    3. Chung DC
    . Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 2001;61:6050–6054.
    OpenUrlAbstract/FREE Full Text
  103. 103.↵
    1. Untergasser G,
    2. Steurer M,
    3. Zimmermann M,
    4. Hermann M,
    5. Kern J,
    6. Amberger A,
    7. Gastl G,
    8. Gunsilius E
    . The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation. Int J Cancer. 2008;122:1539–1547.
    OpenUrlCrossRefPubMed
  104. 104.↵
    1. de Jesus Perez VA,
    2. Alastalo TP,
    3. Wu JC,
    4. Axelrod JD,
    5. Cooke JP,
    6. Amieva M,
    7. Rabinovitch M
    . Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol. 2009;184:83–99.
    OpenUrlAbstract/FREE Full Text
  105. 105.↵
    1. Polakis P
    . Formation of the blood-brain barrier: Wnt signaling seals the deal. J Cell Biol. 2008;183:371–373.
    OpenUrlAbstract/FREE Full Text
  106. 106.↵
    1. Goodwin AM,
    2. D'Amore PA
    . Wnt signaling in the vasculature. Angiogenesis. 2002;5:1–9.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
October 15, 2010, Volume 107, Issue 8
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Transcriptional Regulation of Endothelial Cell Differentiation
    • Wnt Signaling in Endothelial Cells
    • Noncanonical β-Catenin–Independent Wnt Signaling Pathways in Endothelial Cells
    • Canonical Wnt Signaling in the Embryo Vasculature
    • The Role of Wnt in Eye and Brain Vasculature
    • Wnt Mechanism of Action
    • The Complexity of Canonic Wnt Signaling in Endothelial Cells
    • Wnt and Vascular Pathology
    • Conclusions
    • Sources of Funding
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    The Role of Wnt Signaling in Physiological and Pathological Angiogenesis
    Elisabetta Dejana and Michael Kühl
    Circulation Research. 2010;107:943-952, originally published October 14, 2010
    https://doi.org/10.1161/CIRCRESAHA.110.223750

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    The Role of Wnt Signaling in Physiological and Pathological Angiogenesis
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    The Role of Wnt Signaling in Physiological and Pathological Angiogenesis
    Elisabetta Dejana and Michael Kühl
    Circulation Research. 2010;107:943-952, originally published October 14, 2010
    https://doi.org/10.1161/CIRCRESAHA.110.223750
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Endothelium/Vascular Type/Nitric Oxide
    • Vascular Biology
    • Animal Models of Human Disease
    • Angiogenesis

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured